Italian Association Amici di Raoul Follereau (AIFO)

Contact

General

Project Support

Alliances & Links

Resources & Training

ARCHIVES OF LEPROSY MAILING LIST
Archives of recent messages from Leprosy Mailing List (LML) managed by Dr Salvatore Noto.

Over the past few years, LML moderated by Dr Noto has become one of the most important online resource for promoting discussions about leprosy. For joining this mailing list kindly send an email to Dr. Salvatore Noto: salvatore.notoathsanmartino.it  (substitute at with @ in the email address)

Leprosy mailing list – March 1st, 2006

 

Ccn:     all.

Ref.:     Clofazimine and ENL.

From:   G Warren, Sidney, Australia.


 

 

 

Dear All,

 

Regarding the extra Clofazimine 300mgms for ENL (S D Ghate, LML Feb. 27th, 2006) I was the original one who in 1966 realized that this was an effective method of treating ENL and its use often eliminated the need for the more dangerous drugs of Prednisolone and Thalidomide, Lepr Review Vol 39, 61-66. 1968.

 

It is obvious that if the patient is taking the 300 regularly he is taking the 50mgms that is needed for MDT.

 

I have never seen an article stating that the 300mgms meant that the 50mgms included in the MDT pack did not need to be taken.  It is obvious that the 300mgms caps include the 50mgms, so the fact of omitting the separate cap is rarely stated.  One usually only lists the dose the patient is taking Not the ones they do not take.

 

One word of warning, do not give 300mgms daily for more than 2-3 months as some patients do develop undesirable intestinal symptoms of the 300mgms.  It takes 6-8 weeks to build up the maximum anti-inflammatory effect, and is slowly excreted, and so once that is achieved the dose can be reduced slowly adjusting tranquilisers as needed as these patients are often emotionally and psychologically unstable because of having leprosy.  This instability triggers episodes of ENL.

 

Also look for any other medical problem especially infections or endocrine problems (e.g. diabetes -- these are often the trigger factors that produced the ENL in the first place) and treat those.  Until they are controlled the ENL will not be.

 

Grace Warren.

 

 

<< BACK TO LML ARCHIVE INDEX

 

AIFO, Via Borselli 4-6, 40135 Bologna, Italy
Tel: +390-51-4393.211 Fax: +390-51-434046 Email: info@aifo.it